(Q34106722)

31 July 2017

1 reference

title

Novel approaches to targeting neuropeptide systems (English)

1 reference

31 July 2017

B P Roques

1

1 reference

31 July 2017

1 December 2000

1 reference

Trends in Pharmacological Sciences

31 July 2017

1 reference

31 July 2017

21

1 reference

31 July 2017

12

1 reference

31 July 2017

475-483

1 reference

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Aminopeptidase A inhibitors as potential central antihypertensive agents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Evolutionary families of metallopeptidases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Haemodynamic brain responses to acute pain in humans: sensory and attentional networks.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Endogenous opioids implicated in the dynamics of experimental drug addiction: an in vivo autoradiographic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Genotypic differences in mesolimbic enkephalin gene expression in DBA/2J and C57BL/6J inbred mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Phosphorus‐containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: effect on neurotensin degradation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Purification of substance P endopeptidase (SPE) activity in human spinal cord and subsequent comparative studies with SPE in cerebrospinal fluid and with chymotrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Neutral endopeptidase modulation of septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Targeted deletion of the neutral endopeptidase gene alters ventilatory responses to acute hypoxia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Characterization and inhibition of a cholecystokinin-inactivating serine peptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Evidence for a high-affinity uptake system for cholecystokinin octapeptide (CCK8) in rat cortical synaptosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

CCK in anxiety and cognitive processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Decrease in short-term memory function induced by CCK-4 in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Analysis of variation in L-365,260 competition curves in radioligand binding assays

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Opposite effects of CCK(B) agonists in grooming behaviour in rats: further evidence for two CCK(B) subsites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

The endocannabinoid system as a target for therapeutic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

The dual peptidase inhibitor RB101 induces a long-lasting increase in the extracellular level of Met-enkephalin-like material in the nucleus accumbens of freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and antinociceptive activities

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Spinal cord pharmacology of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Analgesic doses of the enkephalin degrading enzyme inhibitor RB 120 do not have discriminative stimulus properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Effect of inhibiting enkephalin catabolism in the VTA on motor activity and extracellular dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Endogenous opioid systems and alcohol addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Drug abuse: hedonic homeostatic dysregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Drug addiction as dopamine-dependent associative learning disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Absence of opiate rewarding effects in mice lacking dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

The dopamine hypothesis of reward: past and current status

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Rewarding effects of opiates are absent in mice lacking the receptor for substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Drug addiction: the yin and yang of hedonic homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Cholecystokinin/opioid interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Delta(2)-opioid receptor mediation of morphine-induced CCK release in the frontal cortex of the freely moving rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCKB receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

Cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-d-aspartate antagonists phencyclidine and dizocilpine maleate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901571-6

7 January 2021

10.1016/S0165-6147(00)01571-6

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11121837